e-ISSN: Pending
Failed Experiment ReportOpen accessNeurology. Diseases of the nervous system

Fingolimod modulates microglial activation to augment markers of remyelination

Baker David; Giovannoni Gavin; Jackson Samuel J · 2011 · Journal of Neuroinflammation

WASTE classifies this as Failed Experiment Report · AI classification, approximate

An experimental approach did not work as intended — learn what to avoid before investing the same effort.

Abstract

Abstract Introduction Microglial activation in multiple sclerosis has been postulated to contribute to long-term neurodegeneration during disease. Fingolimod has been shown to impact on the relapsing remitting phase of disease by modulating autoreactive T-cell egress from lymph organs. In addition, it is brain penetrant and has been shown to exert multiple effects on nervous system cells. Methods In this study, the impact of fingolimod and other sphingosine-1-phosphate receptor active molecules following lysophosphotidyl choline-induced demyelination was examined in the rat telencephalon reagg

Abstract by Baker David; Giovannoni Gavin; Jackson Samuel J, Journal of Neuroinflammation (2011) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1186/1742-2094-8-76